The US Food and Drug Administration has postponed most overseas inspections through April citing federal travel restrictions. One industry expert advises companies to prepare strong documentation in case the FDA begins to remotely conduct paper-based inspections.
On 13 March, the coronavirus crisis reached a new level where President Trump declared it a national emergency allowing national, state and local authorities to use additional emergency funds and...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?